These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 18279624)
81. A sulindac analogue is effective against malignant pleural effusion in mice. Moschos C; Psallidas I; Cottin T; Kollintza A; Papiris S; Roussos C; Stathopoulos GT; Giannis A; Kalomenidis I Lung Cancer; 2011 Aug; 73(2):171-5. PubMed ID: 21227533 [TBL] [Abstract][Full Text] [Related]
82. Toll-like receptor 4 signaling inhibits malignant pleural effusion by altering Th1/Th17 responses. Xu QQ; Zhou Q; Xu LL; Lin H; Wang XJ; Ma WL; Zhai K; Tong ZH; Su Y; Shi HZ Cell Biol Int; 2015 Oct; 39(10):1120-30. PubMed ID: 25939739 [TBL] [Abstract][Full Text] [Related]
83. [The local hyperthermochemotherapy for pleural carcinomatosis]. Tsuboi M; Nagai K; Saitoh H; Furukawa K; Konaka C; Kato H; Kawana K; Abe K Nihon Kyobu Geka Gakkai Zasshi; 1992 Aug; 40(8):1195-202. PubMed ID: 1402161 [TBL] [Abstract][Full Text] [Related]
84. Efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy for malignant pleural effusion: a meta-analysis. Pan X; Hou Z; Zhang T; Ding Z; Ye F; Wang Z; Huang C; Wang P; Li X J Cardiothorac Surg; 2024 May; 19(1):278. PubMed ID: 38711077 [TBL] [Abstract][Full Text] [Related]
85. IL-10 promotes malignant pleural effusion in mice by regulating T Wu XZ; Zhai K; Yi FS; Wang Z; Wang W; Wang Y; Pei XB; Shi XY; Xu LL; Shi HZ Eur J Immunol; 2019 Apr; 49(4):653-665. PubMed ID: 30695099 [TBL] [Abstract][Full Text] [Related]
86. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients. Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959 [TBL] [Abstract][Full Text] [Related]
87. Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer. Hu CY; Zhang YH; Wang T; Chen L; Gong ZH; Wan YS; Li QJ; Li YS; Zhu B Clin Exp Immunol; 2016 Oct; 186(1):106-14. PubMed ID: 27447482 [TBL] [Abstract][Full Text] [Related]
88. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients. Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392 [TBL] [Abstract][Full Text] [Related]
89. Th17/Treg imbalance in malignant pleural effusion. Yang WB; Ye ZJ; Xiang F; Zhang JC; Zhou Q J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):27-32. PubMed ID: 23392703 [TBL] [Abstract][Full Text] [Related]
90. Interleukin 22-producing CD4+ T cells in malignant pleural effusion. Ye ZJ; Zhou Q; Yin W; Yuan ML; Yang WB; Xiang F; Zhang JC; Xin JB; Xiong XZ; Shi HZ Cancer Lett; 2012 Dec; 326(1):23-32. PubMed ID: 22809567 [TBL] [Abstract][Full Text] [Related]
91. [Hyperthermic intrapleural chemotherapy--another modality for the treatment of malignant pleural neoplasia]. Galie N; Tabacu E Pneumologia; 2008; 57(4):246-7. PubMed ID: 19186688 [TBL] [Abstract][Full Text] [Related]
92. Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer. Ma W; Wang K; Du J; Luan J; Lou G Mol Med Rep; 2015 Apr; 11(4):2999-3008. PubMed ID: 25434365 [TBL] [Abstract][Full Text] [Related]
93. Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect? Chen D; Song X; Wang H; Gao Z; Meng W; Chen S; Ma Y; Wang Y; Li K; Yu J; Yue J Front Immunol; 2018; 9():2916. PubMed ID: 30619280 [TBL] [Abstract][Full Text] [Related]
94. TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating T Yi FS; Zhang X; Zhai K; Huang ZY; Wu XZ; Wu MT; Shi XY; Pei XB; Dong SF; Wang W; Yang Y; Du J; Luo ZT; Shi HZ J Immunol; 2020 Nov; 205(10):2926-2935. PubMed ID: 33046503 [TBL] [Abstract][Full Text] [Related]
95. Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0-N1 nonsmall cell lung cancer and malignant pleural effusion? Migliore M; Nardini M Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31366459 [TBL] [Abstract][Full Text] [Related]
96. [Hyperthermia combined with intracavitary injection of drug for malignant pleural effusion]. Cao D; Hou M; Gou H; Zhu J Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):286-8. PubMed ID: 21172165 [TBL] [Abstract][Full Text] [Related]
97. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Oshikawa K; Yanagisawa K; Ohno S; Tominaga S; Sugiyama Y Am J Respir Crit Care Med; 2002 Apr; 165(7):1005-9. PubMed ID: 11934729 [TBL] [Abstract][Full Text] [Related]
98. Th1 and Th2 cytokine response in patients with pulmonary tuberculosis and health care workers occupationally exposed to M. tuberculosis. Cozmei C; Constantinescu D; Carasevici E; Anisie E; Ungureanu D; Sorete-Arbore A; Gramadă D; Mihăescu T; Croitoru C; Popa D Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):702-9. PubMed ID: 18293704 [TBL] [Abstract][Full Text] [Related]
99. Intrapleural instillation of interferon gamma in patients with malignant pleurisy due to lung cancer. Yanagawa H; Haku T; Hiramatsu K; Nokihara H; Takeuchi E; Yano S; Hanibuchi M; Sone S Cancer Immunol Immunother; 1997 Oct; 45(2):93-9. PubMed ID: 9390200 [TBL] [Abstract][Full Text] [Related]
100. A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder. Satyam A; Singh P; Badjatia N; Seth A; Sharma A Urol Oncol; 2011; 29(1):58-65. PubMed ID: 19837616 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]